Angina clinical trials
13 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- VasoStar Vibrational Guidewire System to Facilitate Crossing Coronary Artery Chronic Total Occlusions
- Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries
- MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
- Imaging Coronary Microvascular Dysfunction (CMD) Study
- Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions
- Technical and Translational Development of Cardiovascular Magnetic Resonance (CMR) Imaging
- Cardiology Biobank Registry
- Analysis of Coronary Reactivity Testing With and Without Intracoronary Nitrate Testing
- LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions
- Breaking Fasts Ahead of Cardiac Caths
- Study Targeting Myocardial Perfusion and Symptom Relief in Women With SGLT2 Inhibitors (STRONG)
- Performance of the Acoustic Based CADScor System in Coronary Artery Disease
- Inorganic Nitrate as a Treatment for ANOCA: NO-ANOCA
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Angina” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.